AdaptVac Company
AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines to treat and prevent specific cancers, infectious diseases and immunological disorders. AdaptVac is currently focused on developing a COVID-19 vaccine.
Industry:
Vaccine/Drug
Technology:
COVID
Funding Status:
N/A
Headquarters:
Denmark
Number Of Exists:
N/A
Investment Stage:
N/A
Employee Number:
N/A
Investor Type:
N/A
Founded Date:
N/A